Buy Crypto Markets Spot FuturesGOLD Earn Event Centre

Psyence Biomedical Ltd (PBM)

NASDAQ

$2.47

$--

(0.00%)

Psyence Biomedical Ltd (PBM) Live Price Chart

Page last updated: --

Key Market Data

Market Cap	$2.52M
Open	$2.39
High	$57,533.44
Low	$1.92
Previous Close	$2.47
Price Change	--
Percentage Change	0.00%
Volume	28K

Psyence Biomedical Ltd (PBM) Stock Price Today

Psyence Biomedical Ltd (PBM) is currently trading at $2.47 as of null, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned -3.52% over the past four weeks. Over the last 12 months, Psyence Biomedical Ltd has recorded a -91.47% price change, indicating a weak performance relative to the broader market.

Psyence Biomedical Ltd (PBM) 7-Day Stock Price Changes

Over the past seven days, Psyence Biomedical Ltd has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $2.53 to the latest recorded price of $2.47, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (27,903.875), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, PBM has delivered a -3.52% return over the past month and a -91.47% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Psyence Biomedical Ltd (PBM)

You can buy and trade PBM on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for PBM and Execute Your Trade

Open the trading page, enter PBM in the search bar, select the amount of PBM you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Psyence Biomedical Ltd (PBM)?

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical Ltd Information

Industry	--
Employees	12
Sector	--
Company Website	https://www.psyence.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Psyence Biomedical Ltd?

The latest trading price for Psyence Biomedical Ltd (Common Stock) is $ 2.47, compared with a previous closing price of $ 2.47. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for PBM can be tracked on the live chart and quote section on this page.

2.Is Psyence Biomedical Ltd stock going up or down?

Looking at recent performances, PBM has returned -3.52% over the past month, -88.24% over the last six months and -91.47% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Psyence Biomedical Ltd stock, but keep in mind that past returns do not guarantee future results.

3.Where does PBM currently sit relative to its 52-week high and low?

In the most recent 52-week period, Psyence Biomedical Ltd has traded between a low of $ 1.92 and a high of $ 74.94. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether PBM is currently nearer the top or the bottom of its one-year trading band.

4.How is Psyence Biomedical Ltd classified by sector and industry?

Psyence Biomedical Ltd is classified in the -- sector. In practice, this means Psyence Biomedical Ltd is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing PBM’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Psyence Biomedical Ltd’s performance.

5.Where is Psyence Biomedical Ltd listed and how large is it by market value?

Psyence Biomedical Ltd is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 2.52M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Psyence Biomedical Ltd's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does PBM's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Psyence Biomedical Ltd has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Psyence Biomedical Ltd's financial performance over time?

To follow Psyence Biomedical Ltd's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how PBM is performing and how the market is responding.

8.When is Psyence Biomedical Ltd expected to report earnings?

Psyence Biomedical Ltd's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for PBM, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Psyence Biomedical Ltd's earnings reports?

Psyence Biomedical Ltd's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether PBM is meeting, beating or missing expectations.

10.How can I stay informed about Psyence Biomedical Ltd's results and guidance?

You can stay up to date on Psyence Biomedical Ltd by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for PBM on this page helps you see how new information is being reflected in the stock.

11.Does Psyence Biomedical Ltd pay a regular cash dividend to its shareholders?

Psyence Biomedical Ltd Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor PBM's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for PBM?

Based on the latest earnings data, PBM has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Psyence Biomedical Ltd is an attractive income stock. The dividend payout ratio measures what percentage of earnings Psyence Biomedical Ltd distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Psyence Biomedical Ltd?

Psyence Biomedical Ltd is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is PBM valued in terms of P/E ratio and EPS?

Psyence Biomedical Ltd currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Psyence Biomedical Ltd's earnings. Comparing PBM's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Psyence Biomedical Ltd

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

Arrowhead Research Corporation

ARWR

Aterian, Inc.

ATER

Atlanta Braves Holdings, Inc.

Top Gainers

Browse today's leading gainers in the US stock market

Arrowhead Research Corporation

ARWR

Aterian, Inc.

ATER

Atlanta Braves Holdings, Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

PBM-to-USD Calculator

Amount

PBM

USD

1 PBM = 2.47 USD